HIN Submitted to Grow Digital Health Midlands · Health Innovation Network Application 2026 · NHS-complementary · No replacement of clinical care
Allvi is a multidisciplinary self-management pathway for women with thyroid disease and PCOS, providing structured clinical support, personalised nutrition, and daily specialist access between NHS appointments with no new technology required from patients or clinicians.
Women with thyroid disease and PCOS in the United Kingdom
Allvi provides the structured daily support layer between NHS appointments — reducing unplanned contacts and improving patient preparedness at each clinical review.
Women with thyroid disease and PCOS are chronically underserved by a system designed for acute care. The conditions are highly prevalent, require continuous management, and generate significant downstream NHS cost — yet the standard pathway offers little between appointments.
The consequence is a cohort of patients who are symptomatic, disengaged, and repeatedly accessing primary care without structured support — generating avoidable contacts and compounding comorbidity risk.
Without structured self-management support, symptomatic patients return repeatedly to primary care between scheduled appointments — generating avoidable consultations that compound GP workload.
Thyroid disease and PCOS frequently require input from endocrinology, gynaecology, and dietetics — yet these specialties rarely coordinate. Patients navigate fragmented pathways with no central support.
Patients arrive at 15-minute specialist appointments underprepared — without symptom logs, lifestyle history, or structured questions — reducing clinical value and increasing the likelihood of repeat referrals.
Unmanaged thyroid dysfunction and PCOS are associated with cardiovascular disease, type 2 diabetes, and mental health conditions — all preventable through early, structured self-management support.
Long diagnostic pathways for PCOS — averaging 5+ years — result in delayed treatment, deteriorating metabolic health, and increasing fertility complications that are costly to address at later stages.
Endocrinology and gynaecology waiting lists continue to grow. Without community-based self-management infrastructure, demand on secondary care outpatient services remains structurally unsustainable.
Allvi integrates multidisciplinary support into a coordinated pathway delivered entirely in the community — requiring no new technology from patients and no EPR integration from NHS partners. The pathway is designed to complement, not replace, NHS clinical care.
Comprehensive intake covering symptom history, current NHS care, labs, and lifestyle — establishing a longitudinal baseline.
Initial clinical review with a specialist and registered dietitian — personalised protocol developed and aligned with NHS treatment plan.
Structured symptom tracking and daily specialist messaging — no app or device required.
Evidence-based nutrition, lifestyle, and self-management protocols — updated regularly based on symptom data and lab trends.
Structured symptom logs and clinical summaries prepared for each NHS appointment — improving clinical value of each visit.
Each patient has access to a clinical specialist, registered dietitian, and daily support coordinator — operating as a coordinated team from a single longitudinal record.
The pathway uses communication channels patients already use. No app download, no new account, no digital literacy barrier. No EPR integration required from NHS partners.
Unlike outpatient care, Allvi provides continuous structured support — tracking symptoms, adjusting protocols, and preparing patients for each clinical review over months and years.
Allvi does not diagnose, prescribe, or provide emergency care. All clinical decisions remain with NHS clinicians. Allvi provides the structured self-management layer that the NHS pathway does not currently offer at scale.
Nutrition, lifestyle, and self-management protocols are developed in accordance with NICE guidance for thyroid disease (NG145) and PCOS (CG171) — and reviewed by our clinical advisory team.
The pathway can be deployed across a PCN or ICB population without physical infrastructure — making it immediately scalable to neighbourhood health programme requirements.
Allvi's model was developed with direct reference to the NHS 10-Year Plan and the neighbourhood health agenda — addressing three of the plan's core transformation priorities.
By providing structured daily self-management support between appointments, Allvi reduces avoidable GP follow-up contacts and unplanned primary care attendances — releasing clinician time for patients who require in-person care. Better-prepared patients at specialist appointments increase the clinical value of each outpatient slot.
Allvi provides structured, condition-specific self-management education, symptom tracking, and daily specialist support — enabling women to actively manage their chronic hormonal condition in the community. This aligns directly with the NHS shift from reactive episodic care to proactive, continuous self-management pathways.
With no physical infrastructure requirement, Allvi brings specialist-level multidisciplinary support into the community — meeting patients where they are, reducing access barriers, and operating entirely within the neighbourhood health model without requiring new clinical estate or workforce.
An initial cohort of women with thyroid disease and PCOS — all of whom had been receiving standard NHS care with persistent symptoms — enrolled in the Allvi pathway. Outcomes were assessed at 35 days using validated self-report symptom measures.
All participants had existing NHS diagnoses of hypothyroidism, Hashimoto's thyroiditis, or PCOS. All were currently receiving standard NHS treatment. All reported persistent symptoms despite ongoing clinical care. The Allvi pathway was provided in addition to — not instead of — existing NHS treatment.
* Early real-world data from an initial working prototype cohort. Formal clinical study in development. Individual results may vary. This data is shared for innovation and partnership evaluation purposes.
Rashmi Gupta founded Allvi following her personal experience as a patient with Hashimoto's thyroiditis and hypothyroidism — conditions she managed for years within the NHS system, experiencing firsthand the gap between diagnosis and structured ongoing support.
Rashmi brings a background in scaling digital health and healthcare businesses internationally, with experience across clinical operations, patient engagement, and health system partnerships. Allvi was built on the premise that structured, multidisciplinary self-management pathways — if delivered at community scale — could materially reduce NHS burden while improving patient outcomes.
Allvi is actively seeking NHS partnership to co-design, evaluate, and scale the pathway. Three models are available depending on the partner organisation's objectives and commissioning position.
A funded or co-funded pilot with a PCN, NHS trust, or ICB to evaluate the pathway in a defined patient cohort over 3–6 months.
For NHS organisations ready to commission the pathway as a structured self-management service for a defined patient population.
For NHS trusts and integrated care boards exploring employee health and productivity benefits for clinical and non-clinical staff.
We are actively seeking NHS clinical and commissioning partners to co-design the formal evaluation of the Allvi pathway. If you are a clinical lead, commissioner, or health innovation reviewer interested in exploring what a partnership could look like, we would welcome a conversation.
Direct contact
Rashmi Gupta, Founder
support@allvihealth.com
We aim to respond within one working day.